|
EP3321376A1
|
|
Electrochemical dna detection
|
|
EP3199241A1
|
|
Multi-well test plate assembly and method of preparing a test plate for analysis
|
|
EP2862942A1
|
|
Detection of Streptococcus pneumoniae
|
|
EP2711432A1
|
|
Method for detection of BRAF and PI3K mutations
|
|
EP2607495A1
|
|
Method for detection of KRAS mutations
|
|
ES2372840A1
|
|
KIT FOR THE DETECTION OF THE HUMAN PAPILOMA VIRUS.
|
|
GB0910805D0
|
|
Immobilisation of probe arrays
|
|
MX2010010698A
|
|
Method for detection of herpesvirus in a test sample.
|
|
GB0809881D0
|
|
Method for detecting respiratory viral agents in a test sample
|
|
GB0803461D0
|
|
Device for detection of target-probe interactions
|
|
GB0708576D0
|
|
Method for detecting respiratory viral agents in a test sample
|
|
GB0614620D0
|
|
Assay for diagnosing a predisposition to pathological bone conditions and anticipating response to treatment
|
|
GB0605337D0
|
|
Treatment of CNS conditions
|
|
GB0521716D0
|
|
Modulation of 11beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases
|
|
GB0521351D0
|
|
Modulation of TRPV expression levels
|
|
GB0516145D0
|
|
In vitro diagnostic kit for identification of human papillomavirus in clinical samples
|
|
GB0506612D0
|
|
Methods and compositions to treat asthma
|
|
GB0506299D0
|
|
Methods and compositions to treat asthma
|
|
GB0505081D0
|
|
Downregulation of interleukin-12 expression by means of rnai technology
|
|
GB0504057D0
|
|
Methods and compositions to prevent neuronal degeneration
|
